Related Experiment Video
Updated: Jun 25, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
[Anti-meningococcal vaccines]
Muhamed-Kheir Taha1, Jean-Michel Alonso
1Institut Pasteur, unité des Neisseria, Centre national de référence des mẃningocoques, 75724 Paris Cedex 15, France. mktaha@pasteur.fr
Abstract:
Current anti-meningococcal vaccines are prepared from capsular saccharides (plain or conjugate). They target four serogroups A, C, Y and W135. No vaccine is available against serogroup B saccharide. However, protein-based vaccines (recombinant vaccines or outer membrane vesicle vaccines) allow developing vaccines against serogroup B isolates.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Cryptococcal Meningitis
Viral Meningitis
Vaccines

